- Home
- BR vs PODD Comparison
BR vs PODD Comparison
Compare BR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BR
- PODD
- Stock Information
- Founded
- BR 1962
- PODD 2000
- Country
- BR United States
- PODD United States
- Employees
- BR N/A
- PODD N/A
- Industry
- BR Business Services
- PODD Medical/Dental Instruments
- Sector
- BR Consumer Discretionary
- PODD Health Care
- Exchange
- BR Nasdaq
- PODD Nasdaq
- Market Cap
- BR 26.7B
- PODD 22.1B
- IPO Year
- BR 2007
- PODD 2007
- Fundamental
- Price
- BR $221.00
- PODD $311.95
- Analyst Decision
- BR Buy
- PODD Strong Buy
- Analyst Count
- BR 7
- PODD 19
- Target Price
- BR $265.67
- PODD $338.79
- AVG Volume (30 Days)
- BR 551.2K
- PODD 453.9K
- Earning Date
- BR 11-04-2025
- PODD 11-06-2025
- Dividend Yield
- BR 1.76%
- PODD N/A
- EPS Growth
- BR 21.16
- PODD N/A
- EPS
- BR 7.10
- PODD 3.32
- Revenue
- BR $6,889,100,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- BR $8.17
- PODD $29.27
- Revenue Next Year
- BR $5.22
- PODD $18.30
- P/E Ratio
- BR $31.13
- PODD $93.88
- Revenue Growth
- BR 5.88
- PODD 26.00
- 52 Week Low
- BR $208.20
- PODD $227.03
- 52 Week High
- BR $271.91
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- BR 28.80
- PODD 41.83
- Support Level
- BR $217.89
- PODD $320.76
- Resistance Level
- BR $236.02
- PODD $326.81
- Average True Range (ATR)
- BR 4.60
- PODD 7.35
- MACD
- BR -0.52
- PODD -0.26
- Stochastic Oscillator
- BR 17.15
- PODD 1.89
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.